Chicago Equity Partners’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | $450K | Buy |
9,923
+529
| +6% | +$24K | 0.05% | 455 |
|
|
2019
Q4 | $611K | Buy |
9,394
+586
| +7% | +$38.1K | 0.04% | 594 |
|
|
2019
Q3 | $547K | Sell |
8,808
-6,148
| -41% | -$382K | 0.03% | 660 |
|
|
2019
Q2 | $1.07M | Sell |
14,956
-30,914
| -67% | -$2.2M | 0.05% | 509 |
|
|
2019
Q1 | $3.6M | Buy |
45,870
+4,761
| +12% | +$373K | 0.14% | 202 |
|
|
2018
Q4 | $3.48M | Buy |
41,109
+2,605
| +7% | +$221K | 0.14% | 204 |
|
|
2018
Q3 | $6.59M | Buy |
38,504
+11,894
| +45% | +$2.04M | 0.19% | 147 |
|
|
2018
Q2 | $3.44M | Buy |
26,610
+1,908
| +8% | +$247K | 0.11% | 284 |
|
|
2018
Q1 | $2.55M | Buy |
+24,702
| New | +$2.55M | 0.08% | 329 |
|